Marie-France |
||
Information |
||
TIMC UMR 5525 CNRS-Université Grenoble-Alpes | ||
BNI - Barrières Naturelles et Infectiosité | ||
Grenoble | ||
0000-0002-5423-4094 | ||
This email address is being protected from spambots. You need JavaScript enabled to view it. | ||
https://www-timc.imag.fr/en/bni | ||
Scientific interests and projects |
||
The BNI team is interested in the innate control of Toxoplasma gondii infectivity. Infectivity refers to the capacity of a parasite to infect an individual. It involves pathogenrecognition systems, and the diversification of responses relies on the combined genetic diversity of both host and pathogen. We have established that in the rat model the control of Toxoplasma infectivity is genetically controlled by Toxo1, a single locus located on the rat chromosome 10. In resistant rats, the parasite elimination occurs at the site of infection (intestinal barrier) and involves the rapid killing of infected resident macrophages which in turn contributes to the lack of parasite dissemination. In vitro, infected resistant rat macrophages trigger the NOD-like receptor NLRP1a/Caspase-1 pathway to induce the death of both parasites and their hosting macrophages. This is parasite-induced and differs among T. gondii genotypes. Thus, having demonstrated that the parasite fate depends on both the Toxo1 locus genotype (LEW or BN origin) and the parasite genotype, we are interested in the characterization of factor(s) and pathway(s) which activate the Toxo1- dependent resistance to toxoplasmosis. Our ongoing strategy is based on global comparative analyses of -i) resistant vs susceptible macrophages functions before and following parasite infection and -ii) a set of parasite mutant vs wildtype capable to bypass the resistance. Bioinformatics analysis will combine results from comparative proteomics, transcriptomics and metabolics. Candidate signaling/metabolic host pathway(s) and gene(s) will be validated using classical reverse genetics, biochemical and cellular studies |
||
Top 5 publications of the last 5 years |
||
1. Cavailles P, Flori P, Papapietro O, Bisanz C, Massera C, Cristinelli S, Jublot D, Bastien O, Loeuillet C, Aldebert D, Touquet Lagrange D, Pilloux Ludovic, B, Fournié GJ and MF Cesbron-Delauw (2014) A highly conserved Toxo1 haplotype directs resistance to toxoplasmosis and its associated caspase-1 dependent killing of parasite and host macrophage. PLoS Path. 10(4), e1004005. doi: 10.1371/journal.ppat.1004005 2. Mercier C and MF Cesbron-Delauw (2015) Toxoplasma secretory granules: one population or more? Trends Parasitol. 31: 60-71. doi: 10.1016/j.pt.2014.12.002 3. Lopez J., Bittame A, Massera C, Vasseur V, Effantin G, Valat A, Buaillon C, Allart S, Fox BA, Rommereim LM, Bzik DJ, Schoen G, Weissenhorn W, Dubremetz JF, Gagnon J, Mercier C, Cesbron-Delauw MF and N Blanchard (2015) Intravacuolar membranes regulate CD8 T cell recognition of membrane-bound Toxoplasma gondii protective antigen. Cell Reports 13: 2273-2286. doi: 10.1016/j.celrep.2015.11.001 4. Touquet B, Pellissier E, Cavailles P, Yi W, Bellini V, Mercier M, Cesbron-Delauw MF, Boumendjel A and D Aldebert (2018) High-content imaging assay to evaluate Toxoplasma gondii infection and proliferation: a multiparametric assay to screen new compounds. PLoS One 13(8):e0201678. doi: https://doi.org/10.1371/journal.pone.0201678. 5. Loeuillet C., Mondon A., Kamche S., Curri V., Boutonnat J., Cavaillès P. and MF Cesbron- Delauw (2019). Toxoplasma hypervirulence in the rat model parallels human infection and is modulated by the Toxo1 locus. Front. Cell. Infection Microbiol. 9 :13 doi: 10.3389/fcimb.2019.00134 |
Postdoctoral position, Institut Pasteur, Paris, France A 24-month post-doctoral position starting on March 1st 2025 and funded by the French National Research Agency (ANR) is available in the Trypanosome...
Postdoctoral positions, LPHI Lab, Montpellier, France Two ERC-funded (JANUS 2024-2029) postdoc positions are open in the lab to study cell cycle regulation in malaria...
Postdoctoral position, Institut Pasteur, Paris, France A postdoc position is available at the Institut Pasteur Paris, in the signalling and host-parasite interactions research group, headed by Dr Najma Rachidi...
ABOUT SPEAKERS PROGRAMME REGISTRATION CONTACT LOCATION About the workshop ParaFrap is organizing the ParaFrap Next Generation in Parasitology...
[Communiqué] As part of the actions of the Health Innovation Plan 2030, the health component of the France 2030 plan, Mohamed-Ali Hakimi is one of the 22 laureates of an Excellence Chair in Biology/Health, supported to conduct high-level research...
The York Biomedical Research Institute (YBRI) are hosting an online live seminar on Friday 24th May 1-2pm BST as part of their biomedical science seminar series. You are all welcome to attend - registration is required via the...
[Communiqué] Congratulations to Arthur Talman, IRD Research Leader in the MIVEGEC laboratory (Montpellier), who has been awarded an Advanced Grant from the European Research Council (ERC) for the project "TROJAN - Molecular mimicry and immune...
Ana Rita Gomes, a CNRS Research Associate at the Laboratory of Pathogens and Host Immunity in Montpellier, and former Postdoctoral fellow of the LabEx ParaFrap, has been awarded the prestigious CNRS Bronze Medal in 2023. This...
Happy New Year 2024! To kick off this new scientific year, here is the ParaFrap webinar schedule. Since January 2021, ParaFrap has been organizing a series of webinars. This monthly event, held every 2nd Thursday of the month, aims to strengthen...
The team of Dr. Mohamed-Ali Hakimi, in collaboration with Isabelle Coppens (Johns Hopkins University Bloomberg School of Public Health and Malaria Research Institute, Baltimore, MD, USA), has developed a new (epi)genetic method to produce in vitro...
© 2023. All rights reserved MLCOM
Notre site LabEx ParaFrap utilise des cookies pour réaliser des statistiques de visites, partager des contenus sur les réseaux sociaux et améliorer votre expérience. En refusant les cookies, certains services seront amenés à ne pas fonctionner correctement. Nous conservons votre choix pendant 30 jours. Vous pouvez changer d'avis en cliquant sur le bouton 'Cookies' en bas à gauche de chaque page de notre site. En savoir plus
Ce site utilise des cookies pour assurer son bon fonctionnement et ne peuvent pas être désactivés de nos systèmes. Nous ne les utilisons pas à des fins publicitaires. Si ces cookies sont bloqués, certaines parties du site ne pourront pas fonctionner.
Ce site utilise des cookies de mesure et d’analyse d’audience, tels que Google Analytics et Google Ads, afin d’évaluer et d’améliorer notre site internet.
Ce site utilise des composants tiers, tels que NotAllowedScript677a18ee5bb88ReCAPTCHA, Google NotAllowedScript677a18ee5b701Maps, MailChimp ou Calameo, qui peuvent déposer des cookies sur votre machine. Si vous décider de bloquer un composant, le contenu ne s’affichera pas
Des plug-ins de réseaux sociaux et de vidéos, qui exploitent des cookies, sont présents sur ce site web. Ils permettent d’améliorer la convivialité et la promotion du site grâce à différentes interactions sociales.
Ce site web utilise un certain nombre de cookies pour gérer, par exemple, les sessions utilisateurs.